Shares of Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report) were up 1.3% on Wednesday . The company traded as high as $0.16 and last traded at $0.16. Approximately 606 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 20,770 shares. The stock had previously closed at $0.16.
Guided Therapeutics Stock Down 25.3 %
The stock has a market capitalization of $7.75 million, a price-to-earnings ratio of -4.23 and a beta of 0.49. The company has a 50 day simple moving average of $0.17 and a 200-day simple moving average of $0.15.
Guided Therapeutics Company Profile
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Featured Articles
- Five stocks we like better than Guided Therapeutics
- 3 Small Caps With Big Return Potential
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- What is a Stock Market Index and How Do You Use Them?
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
